{"disease":{"id":"periodic-fever","name":"periodic fever"},"drugs":{"marketed":[{"drug_id":"canakinumab","indication_name":"TNF receptor-associated periodic fever syndrome (TRAPS)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ilaris","generic_name":"CANAKINUMAB","company_name":"Novartis Pharms","drug_phase":"marketed","molecular_target":"Interleukin-1 beta","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":59,"revenue":"1369","mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00001373","title":"Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05656365","title":"Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02059291","title":"Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07476625","title":"Efficacy and Safety of Thalidomide for Pediatric PFAPA Syndrome","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":106,"lead_sponsor_name":"Wenjie Zheng","has_results":false},{"nct_id":"NCT05027373","title":"Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.","has_results":false},{"nct_id":"NCT02334748","title":"A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06838143","title":"Ilaris NIS in Korea","phase":"","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05995288","title":"Homeopathic Treatment of Children Suffering From PFAPA","phase":"","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Michael Frass","has_results":false},{"nct_id":"NCT02911857","title":"An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}